Wednesday, February 10, 2010, 8:32am EST - Canadian Markets open in 58 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Cleveland BioLabs, Inc. (CBLI)

On Feb 9: 3.85 USD   0.00 (0.00%)  
MORE ON CBLI
Quotes
Charts
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials
Headlines Get Headlines for:
Tue, Feb 2, 2010
CLEVELAND BIOLABS INC Files SEC form 8-K, Other Events
EDGAR Online (Tue, Feb 2)
Thu, Jan 28, 2010
Cleveland BioLabs Granted European Patent for Radiation Protection Drug CBLB502
Marketwire (Thu, Jan 28)
Wed, Jan 27, 2010
Cleveland BioLabs to Present at 12th Annual BIO CEO & Investor Conference
Marketwire (Wed, Jan 27)
Thu, Jan 21, 2010
Buffalo researcher lands $1.7M grant
at bizjournals.com (Thu, Jan 21)
Tue, Jan 19, 2010
Cleveland BioLabs Doses First Volunteers in Second Safety Study for CBLB502
Marketwire (Tue, Jan 19)
Tue, Jan 12, 2010
Cleveland BioLabs to Respond to Department of Defense Request for Proposal for Radiation Countermeasure
Marketwire (Tue, Jan 12)
Wed, Jan 6, 2010
Sunesis, Taser: Midday Volume Plays
at TheStreet.com (Wed, Jan 6)
Cleveland BioLabs Receives First U.S. Patent for Radiation Protection Drug CBLB502
Marketwire (Wed, Jan 6)
Tue, Jan 5, 2010
CLEVELAND BIOLABS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Stateme
EDGAR Online (Tue, Jan 5)
Cleveland BioLabs to Present at OneMedForum
Marketwire (Tue, Jan 5)
Wed, Dec 30, 2009
PharmAthene, ICX Technologies: Midday Volume Plays
at TheStreet.com (Wed, Dec 30)
Cleveland BioLabs Establishes Joint Venture to Develop Curaxin Compounds for Cancer Applications
Marketwire (Wed, Dec 30)
Tue, Dec 22, 2009
Cleveland BioLabs President and CEO Reports Progress on Clinical and Corporate Developments
Marketwire (Tue, Dec 22)
Mon, Nov 23, 2009
Cleveland BioLabs Opens Enrollment of Second Safety Study for CBLB502
Marketwire (Mon, Nov 23)
Wed, Nov 18, 2009
Cleveland BioLabs Publishes New Insights Into Mechanism of Action of Curaxins, Extending Their Clinical Potential
Marketwire (Wed, Nov 18)
CLEVELAND BIOLABS INC Financials
EDGAR Online Financials (Wed, Nov 18)
Thu, Nov 12, 2009
CLEVELAND BIOLABS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Thu, Nov 12)
Mon, Nov 2, 2009
Cleveland BioLabs to Present at Merriman 6th Annual Investor Summit
Marketwire (Mon, Nov 2)
Tue, Oct 20, 2009
Cleveland BioLabs to Host Roundtable on Protectan CBLB502 for Acute Radiation Syndrome
Marketwire (Tue, Oct 20)
Mon, Oct 19, 2009
Cleveland BioLabs to Present at 8th Annual BIO Investor Forum
Marketwire (Mon, Oct 19)
Older Headlines
View headlines from:

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Headlines for Another Symbol:
Symbol Lookup
Latest News Canadian Indices